ABOUT ABBV-744 AS A POTENTIAL THERAPEUTIC OPTION FOR AGGRESSIVE CANCERS

RUNX1 is a master transcription aspect that regulates the expression of many genes needed for hematopoiesis. Studies implied that the RUNX1- Participant consumed grapefruit or grapefruit goods within three days before the main dose of study drug.Phase one: Researchers check a whole new drug or treatment in a small team of people for the first time